Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus

We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy. We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016....

Full description

Saved in:
Bibliographic Details
Published inRadiation oncology journal Vol. 35; no. 3; pp. 268 - 273
Main Authors Park, Sunmin, Yoon, Sang Min, Lee, Sumin, Park, Jin-hong, Song, Si Yeol, Lee, Sang-wook, Ahn, Seung Do, Kim, Jong Hoon, Choi, Eun Kyung
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society for Radiation Oncology 01.09.2017
대한방사선종양학회
Subjects
Online AccessGet full text
ISSN2234-1900
2234-3156
2234-3156
2234-3164
DOI10.3857/roj.2017.00199

Cover

Abstract We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy. We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31-65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm (range, 6.8-83.2 cm ), and fractionated radiation was administered to a total dose of 50-54 Gy with a daily dose of 2 Gy. The median follow-up period was 6.8 years (range, 2.2-8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9-95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy. Fractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus.
AbstractList We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy. We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31-65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm (range, 6.8-83.2 cm ), and fractionated radiation was administered to a total dose of 50-54 Gy with a daily dose of 2 Gy. The median follow-up period was 6.8 years (range, 2.2-8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9-95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy. Fractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus.
Purpose: We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy. Materials and Methods: We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31–65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm3 (range, 6.8–83.2 cm3), and fractionated radiation was administered to a total dose of 50–54 Gy with a daily dose of 2 Gy. Results: The median follow-up period was 6.8 years (range, 2.2–8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9–95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy. Conclusion: Fractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus. KCI Citation Count: 0
We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.PURPOSEWe performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31-65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm3 (range, 6.8-83.2 cm3), and fractionated radiation was administered to a total dose of 50-54 Gy with a daily dose of 2 Gy.MATERIALS AND METHODSWe analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31-65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm3 (range, 6.8-83.2 cm3), and fractionated radiation was administered to a total dose of 50-54 Gy with a daily dose of 2 Gy.The median follow-up period was 6.8 years (range, 2.2-8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9-95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy.RESULTSThe median follow-up period was 6.8 years (range, 2.2-8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9-95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy.Fractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus.CONCLUSIONFractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus.
Author Yoon, Sang Min
Song, Si Yeol
Park, Jin-hong
Choi, Eun Kyung
Ahn, Seung Do
Lee, Sumin
Lee, Sang-wook
Kim, Jong Hoon
Park, Sunmin
Author_xml – sequence: 1
  givenname: Sunmin
  surname: Park
  fullname: Park, Sunmin
– sequence: 2
  givenname: Sang Min
  surname: Yoon
  fullname: Yoon, Sang Min
– sequence: 3
  givenname: Sumin
  surname: Lee
  fullname: Lee, Sumin
– sequence: 4
  givenname: Jin-hong
  surname: Park
  fullname: Park, Jin-hong
– sequence: 5
  givenname: Si Yeol
  surname: Song
  fullname: Song, Si Yeol
– sequence: 6
  givenname: Sang-wook
  surname: Lee
  fullname: Lee, Sang-wook
– sequence: 7
  givenname: Seung Do
  surname: Ahn
  fullname: Ahn, Seung Do
– sequence: 8
  givenname: Jong Hoon
  surname: Kim
  fullname: Kim, Jong Hoon
– sequence: 9
  givenname: Eun Kyung
  surname: Choi
  fullname: Choi, Eun Kyung
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29037018$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002267247$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFkc1v3CAQxVGVqknTXHusOLaH3QwYsLlUiqJ-RIpUKdqeEcY4S2KDCzjR_vfF2e2nVJXLIPF785g3L9GRD94i9JrAump4fR7D3ZoCqdcARMpn6ITSiq0qwsXR4U4kwDE6S-kOyhHAhYAX6JhKqGogzQna3ITB4tDjPmqTXfA62w5H3bmQtzbqaYedx5POzvqc8KPLW7y1o_a3Lox6ERYMG_1gow9zwsn5Ob1Cz3s9JHt2qKfo68cPm8vPq-svn64uL65XhlGWV7QlBFj5YtcKEJ0AQ3rouKbEsLprbW9aZghUhFYNbS2vaya7tgVuQBLWyOoUvdv39bFX98apoN1TvQ3qPqqLm82VokKCbHhhz_fs7Ce9e9TDoKboRh13ioBa4lQlTrXEqZ7iLIr3e8U0t6PtTAkg6l-qxevPF--2xflBccHqmtPS4O2hQQzfZpuyGl0ydhi0tyUrRSSnBISgTUHf_O710-THogrA9oCJIaVoe2Vc1svCirUb_j3D-i_Zf4b-DoTvt5U
CitedBy_id crossref_primary_10_1080_02688697_2021_1958154
crossref_primary_10_3390_cancers15071999
crossref_primary_10_3892_etm_2024_12763
crossref_primary_10_1016_j_wneu_2018_11_015
crossref_primary_10_3171_2021_7_JNS21955
crossref_primary_10_1016_j_wneu_2018_12_185
crossref_primary_10_1016_j_wneu_2023_07_068
crossref_primary_10_1186_s12894_019_0441_0
crossref_primary_10_3389_fneur_2020_00355
crossref_primary_10_1016_j_wneu_2017_11_177
crossref_primary_10_1007_s43465_020_00295_0
crossref_primary_10_1227_ons_0000000000000180
Cites_doi 10.1016/0360-3016(91)90171-Y
10.3171/foc.2006.21.1.7
10.1016/j.clineuro.2014.09.025
10.1007/s00066-006-1473-4
10.4103/0973-029X.141321
10.2176/nmc.40.575
10.1007/BF00314842
10.1007/s11060-011-0753-8
10.3892/ol.2015.4053
10.3171/jns.1987.67.6.0919
10.1227/01.NEU.0000124750.13721.94
10.1007/s00701-015-2657-4
10.1016/j.ijrobp.2011.12.051
10.1227/00006123-199008000-00024
10.1097/00006123-199201000-00018
10.2176/nmc.32.93
10.1016/j.ijrobp.2009.07.1753
10.1227/01.NEU.0000378026.23116.E6
10.1007/s11060-014-1414-5
10.3171/2009.6.JNS08271
10.1007/s00066-004-1266-6
ContentType Journal Article
Copyright Copyright © 2017. The Korean Society for Radiation Oncology 2017
Copyright_xml – notice: Copyright © 2017. The Korean Society for Radiation Oncology 2017
DBID AAYXX
CITATION
NPM
7X8
5PM
ADTOC
UNPAY
ACYCR
DOI 10.3857/roj.2017.00199
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2234-3156
2234-3164
EndPage 273
ExternalDocumentID oai_kci_go_kr_ARTI_2690985
10.3857/roj.2017.00199
PMC5647752
29037018
10_3857_roj_2017_00199
Genre Journal Article
GroupedDBID 5-W
8JR
8XY
9ZL
AAKDD
AAYXX
ABDBF
ACUHS
ADBBV
ADRAZ
AEGXH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
EF.
GX1
HYE
KQ8
M48
OK1
PGMZT
RPM
KVFHK
NPM
7X8
5PM
ADTOC
UNPAY
.UV
ACYCR
ID FETCH-LOGICAL-c424t-2b1104190db606d60c1f0d5a21c47dbefcb4c10312382be57749dbb05c0914893
IEDL.DBID M48
ISSN 2234-1900
2234-3156
IngestDate Tue Nov 21 21:43:11 EST 2023
Wed Aug 20 00:16:04 EDT 2025
Thu Aug 21 17:57:30 EDT 2025
Fri Jul 11 14:45:21 EDT 2025
Wed Feb 19 02:43:53 EST 2025
Tue Jul 01 01:32:54 EDT 2025
Thu Apr 24 23:00:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Cavernous sinus
Radiotherapy
Hemangioma
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
cc-by-nc
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c424t-2b1104190db606d60c1f0d5a21c47dbefcb4c10312382be57749dbb05c0914893
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3857/roj.2017.00199
PMID 29037018
PQID 1952106628
PQPubID 23479
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_2690985
unpaywall_primary_10_3857_roj_2017_00199
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5647752
proquest_miscellaneous_1952106628
pubmed_primary_29037018
crossref_citationtrail_10_3857_roj_2017_00199
crossref_primary_10_3857_roj_2017_00199
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-09-01
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Radiation oncology journal
PublicationTitleAlternate Radiat Oncol J
PublicationYear 2017
Publisher The Korean Society for Radiation Oncology
대한방사선종양학회
Publisher_xml – name: The Korean Society for Radiation Oncology
– name: 대한방사선종양학회
References ref13
ref12
ref15
ref14
ref20
ref11
ref10
ref21
ref2
ref1
ref17
ref16
ref19
ref18
ref8
ref7
ref9
ref4
ref3
ref6
ref5
11109795 - Neurol Med Chir (Tokyo). 2000 Nov;40(11):575-80
25364160 - J Oral Maxillofac Pathol. 2014 Sep;18(Suppl 1):S117-20
9007890 - Neurosurg Rev. 1996;19(4):261-4
26658989 - Acta Neurochir (Wien). 2016 Feb;158(2):313-8
3681431 - J Neurosurg. 1987 Dec;67(6):919-22
16520913 - Strahlenther Onkol. 2006 Mar;182(3):179-82
15157295 - Neurosurgery. 2004 Jun;54(6):1385-93; discussion 1393-4
22361080 - Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e223-30
15592695 - Strahlenther Onkol. 2004 Dec;180(12):758-67
26893777 - Oncol Lett. 2016 Feb;11(2):1545-1548
2385350 - Neurosurgery. 1990 Aug;27(2):306-10
22086238 - J Neurooncol. 2012 Apr;107(2):239-45
20171514 - Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S28-35
25459244 - Clin Neurol Neurosurg. 2014 Dec;127:59-64
16859259 - Neurosurg Focus. 2006 Jul 15;21(1):e6
1738435 - Neurosurgery. 1992 Jan;30(1):101-8
20647963 - Neurosurgery. 2010 Sep;67(3):611-6; discussion 616
24584749 - J Neurooncol. 2014 May;118(1):163-8
1376867 - Neurol Med Chir (Tokyo). 1992 Feb;32(2):93-5
19612972 - J Neurosurg. 2010 Apr;112(4):772-9
2032882 - Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
References_xml – ident: ref21
  doi: 10.1016/0360-3016(91)90171-Y
– ident: ref3
  doi: 10.3171/foc.2006.21.1.7
– ident: ref17
  doi: 10.1016/j.clineuro.2014.09.025
– ident: ref11
  doi: 10.1007/s00066-006-1473-4
– ident: ref1
  doi: 10.4103/0973-029X.141321
– ident: ref5
  doi: 10.2176/nmc.40.575
– ident: ref9
  doi: 10.1007/BF00314842
– ident: ref13
  doi: 10.1007/s11060-011-0753-8
– ident: ref16
  doi: 10.3892/ol.2015.4053
– ident: ref6
  doi: 10.3171/jns.1987.67.6.0919
– ident: ref10
  doi: 10.1227/01.NEU.0000124750.13721.94
– ident: ref15
  doi: 10.1007/s00701-015-2657-4
– ident: ref12
  doi: 10.1016/j.ijrobp.2011.12.051
– ident: ref7
  doi: 10.1227/00006123-199008000-00024
– ident: ref4
  doi: 10.1097/00006123-199201000-00018
– ident: ref8
  doi: 10.2176/nmc.32.93
– ident: ref20
  doi: 10.1016/j.ijrobp.2009.07.1753
– ident: ref2
  doi: 10.1227/01.NEU.0000378026.23116.E6
– ident: ref14
  doi: 10.1007/s11060-014-1414-5
– ident: ref18
  doi: 10.3171/2009.6.JNS08271
– ident: ref19
  doi: 10.1007/s00066-004-1266-6
– reference: 20171514 - Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S28-35
– reference: 22086238 - J Neurooncol. 2012 Apr;107(2):239-45
– reference: 26893777 - Oncol Lett. 2016 Feb;11(2):1545-1548
– reference: 15592695 - Strahlenther Onkol. 2004 Dec;180(12):758-67
– reference: 26658989 - Acta Neurochir (Wien). 2016 Feb;158(2):313-8
– reference: 25459244 - Clin Neurol Neurosurg. 2014 Dec;127:59-64
– reference: 1376867 - Neurol Med Chir (Tokyo). 1992 Feb;32(2):93-5
– reference: 25364160 - J Oral Maxillofac Pathol. 2014 Sep;18(Suppl 1):S117-20
– reference: 20647963 - Neurosurgery. 2010 Sep;67(3):611-6; discussion 616
– reference: 16520913 - Strahlenther Onkol. 2006 Mar;182(3):179-82
– reference: 22361080 - Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e223-30
– reference: 9007890 - Neurosurg Rev. 1996;19(4):261-4
– reference: 3681431 - J Neurosurg. 1987 Dec;67(6):919-22
– reference: 2032882 - Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
– reference: 15157295 - Neurosurgery. 2004 Jun;54(6):1385-93; discussion 1393-4
– reference: 11109795 - Neurol Med Chir (Tokyo). 2000 Nov;40(11):575-80
– reference: 24584749 - J Neurooncol. 2014 May;118(1):163-8
– reference: 1738435 - Neurosurgery. 1992 Jan;30(1):101-8
– reference: 2385350 - Neurosurgery. 1990 Aug;27(2):306-10
– reference: 19612972 - J Neurosurg. 2010 Apr;112(4):772-9
– reference: 16859259 - Neurosurg Focus. 2006 Jul 15;21(1):e6
SSID ssj0000605660
Score 2.1138072
Snippet We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy. We...
We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.PURPOSEWe...
Purpose: We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy....
SourceID nrf
unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 268
SubjectTerms Original
방사선과학
Title Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus
URI https://www.ncbi.nlm.nih.gov/pubmed/29037018
https://www.proquest.com/docview/1952106628
https://pubmed.ncbi.nlm.nih.gov/PMC5647752
https://www.e-roj.org/upload/pdf/roj-2017-00199.pdf
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002267247
UnpaywallVersion publishedVersion
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Radiation oncology journal , 2017, 35(3), , pp.268-273
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2234-3156
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000605660
  issn: 2234-1900
  databaseCode: KQ8
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2234-3156
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000605660
  issn: 2234-1900
  databaseCode: ABDBF
  dateStart: 20120901
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2234-3156
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000605660
  issn: 2234-1900
  databaseCode: DIK
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2234-3156
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000605660
  issn: 2234-1900
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2234-3156
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000605660
  issn: 2234-1900
  databaseCode: 5-W
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central (Free e-resource, activated by CARLI)
  customDbUrl:
  eissn: 2234-3156
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000605660
  issn: 2234-1900
  databaseCode: RPM
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2234-3156
  dateEnd: 20250630
  omitProxy: true
  ssIdentifier: ssj0000605660
  issn: 2234-1900
  databaseCode: M48
  dateStart: 20120901
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELVoOcAFgSgQCpWLKpWLkeM6m-SAEEJULVI5oK7Um-XPkjZ12mRXsP-emSRdumIRnKLIk1iesTNvHM8bQvac8JifyJn23DHpJhNmciuZC0IEWIEm9xgonnydHE3ll7Ps7Pf5p1GB3drQDutJTdv63c-bxQdY8O8x4iwgoG-bCzyjhVyEaVlukPvglQTO8JMR6g9fZXD1fdIwOETJwA_ygcNxzStWfNRGbMM6-PnnKcoH83itFz90Xd9xUYePyaMRW9KPw2R4Qu75-JScfmtqT5tAQzvkMAC4dLTVrhpzrxa0inSkV-0o7stSJHKN51VzpfFBEKNWY0neZt7RrorzbotMDz-ffjpiYykFZqWQMyYMuHkJg3YGIhY34TYN3GVapFbmzvhgjbRY8QE8uDA-A1BYOmN4ZgFPID_NM7IZm-hfEKpLnxuuCxkgOJSZL4Q3NnUh8ML6ojAJYbfKU3bkGcdyF7WCeAOVrUDZCpWtemUnZH8pfz0wbPxV8g3YQl3aSiEpNl7PG3XZKoD-x0pAnF8WWUJ2b02lYKXg7w8dPehHpSVAFSS8LxLyfDDdskNR8oOcp9CSrxh1KYAdrrbE6nvPxp1hKm8mEvJ2af5_jOPlf494mzzEm-FM2yuyOWvn_jWAoJnZ6Wf3Tr879QsOsAWf
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+fractionated+radiotherapy+in+patients+with+hemangioma+of+the+cavernous+sinus&rft.jtitle=Radiation+oncology+journal&rft.au=Park%2C+Sunmin&rft.au=Yoon%2C+Sang+Min&rft.au=Lee%2C+Sumin&rft.au=Park%2C+Jin-hong&rft.date=2017-09-01&rft.issn=2234-1900&rft.eissn=2234-3156&rft.volume=35&rft.issue=3&rft.spage=268&rft.epage=273&rft_id=info:doi/10.3857%2Froj.2017.00199&rft.externalDBID=n%2Fa&rft.externalDocID=10_3857_roj_2017_00199
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-1900&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-1900&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-1900&client=summon